Search our Innovation Portfolio

BioEP is a tool to help clinicians diagnose epilepsy. It uses data from routine EEG tests to create a computational model of the brain. Using the model, BioEP can indicate the ability of the brain to produce epileptic seizure activity and therefore indicate support for a diagnosis of epilepsy or not.

BioEP empowers clinicians with additional information and can be particularly useful when EEGs do not capture any information that is helpful in supporting a diagnosis of epilepsy. BioEP has the potential to speed up reaching an accurate diagnosis and our aim is that this will help people with suspected epilepsy.

Transdermal Diagnostics' product is a non-invasive, Continuous Glucose Monitoring (CGM) system designed to assist individuals in managing their blood sugar levels. The innovation is a biowearable device which includes disposable sensor patches and a rechargeable electronic transmitter. The transmitter wirelessly sends data to specialized software algorithms and readings are accessible through a mobile phone app. This software interprets the signals from the sensors, continuously displays data and stores these readings over extended periods, allowing users to monitor their glucose levels regularly without the need for multiple daily finger sticks.

Augmented Reality app for children and young people in the first year following diagnosis with epilepsy tailored to each individual to enhance patient and carer understanding of epilepsy, provide safety advice for greater confidence in managing epilepsy at home and enable greater communication with clinicians to improve patient outcomes. This will make use of augmented reality to show patients how their epilepsy occurs and how their treatment works. The information will also be tailored to each user's learning level and made available on a wide range of mobile devices so that as many people as possible can use the app.